The development of nanoscale formulations (NFs) in biotherapeutics has revolutionised drug delivery, diagnostics, and treatment strategies, resulting in a new era of precision medicine. NFs were developed to overcome the limitations of conventional drug delivery systems and navigate biological barriers effectively. This chapter highlights the crucial role of NFs in developing personalised and effective therapies. Additionally, the chapter provides a thorough understanding of the synthetic methods, characterisations, and the application of various NFS in biotherapeutics. Moreover, the integration of NFs within various therapeutic platforms, including antibody conjugation, protein fusion, gene expression and monoclonal-antibody delivery, are discussed within this chapter. Subsequently, the benefits, limitations and enhancement strategies associated with NFs drug bioavailability, targeting specificity, stability, and the potential for controlled release will be discussed The final section discusses emerging trends, future perspectives, and key recommendations for advancing the field of nanomedicine, spotlighting its potential to address limitations in current therapeutic approaches.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Nanoscale Formulation Techniques for Biotherapeutics

  • Fezile Motsoene,
  • Sivakumar Singaravelu,
  • Heidi Abrahamse,
  • Sathish Sundar Dhilip Kumar

摘要

The development of nanoscale formulations (NFs) in biotherapeutics has revolutionised drug delivery, diagnostics, and treatment strategies, resulting in a new era of precision medicine. NFs were developed to overcome the limitations of conventional drug delivery systems and navigate biological barriers effectively. This chapter highlights the crucial role of NFs in developing personalised and effective therapies. Additionally, the chapter provides a thorough understanding of the synthetic methods, characterisations, and the application of various NFS in biotherapeutics. Moreover, the integration of NFs within various therapeutic platforms, including antibody conjugation, protein fusion, gene expression and monoclonal-antibody delivery, are discussed within this chapter. Subsequently, the benefits, limitations and enhancement strategies associated with NFs drug bioavailability, targeting specificity, stability, and the potential for controlled release will be discussed The final section discusses emerging trends, future perspectives, and key recommendations for advancing the field of nanomedicine, spotlighting its potential to address limitations in current therapeutic approaches.